Comparison of a Stable Isotope-Labeled and an Analog Internal Standard for the Quantification of Everolimus by a Liquid Chromatography–Tandem Mass Spectrometry Method-Reference-Cited by-同舟云学术

Comparison of a Stable Isotope-Labeled and an Analog Internal Standard for the Quantification of Everolimus by a Liquid Chromatography–Tandem Mass Spectrometry Method

Published:2013-04 Issue:2 Volume:35 Page:246-250
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Heideloff Courtney,Payto Drew,Wang Sihe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.;Gabardi;Pharmacotherapy,2010

2. The role of therapeutic monitoring of everolimus in solid organ transplantation.;Mabasa;Ther Drug Monit,2005

3. . Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.;Johnson-Davis;Ther Drug Monit,2011

4. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.;Bouzas;Ups J Med Sci,2009

5. Evaluation of QMS everolimus assay using Hitachi 917 analyzer: comparison with liquid chromatographymass spectrometry.;Dasgupta;Ther Drug Monit,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrogen/deuterium exchange mass spectrometry in the world of small molecules;Mass Spectrometry Reviews;2021-12-02

2. Limitations of deuterium‐labeled internal standards for quantitative electrospray ionization mass spectrometry analysis of fatty acid metabolites;Rapid Communications in Mass Spectrometry;2020-05-25

3. Bioanalytical LC–MS/MS validation of therapeutic drug monitoring assays in oncology;Biomedical Chromatography;2019-11-27

4. A validated UPLC–MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor (MLIF) in human plasma and its application to a pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2018-08

5. Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC–MS/MS and its application to a PK study;Bioanalysis;2018-06-01